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Regulation of Cytosolic Phospholipase A2 (cPLA2)
and Its Association with Cell Proliferation in Human
Lens Epithelial Cells
Yin Wang,1,2 Kui-Yi Xing,1,2 and Marjorie F. Lou1,2,3
PURPOSE. To investigate the molecular mechanism for cytosolic
phospholipase A2 (cPLA2) regulation and its association to
platelet-derived growth factor (PDGF)-induced cell prolifera-
tion.
METHODS. cPLA2 was examined using human lens epithelial
(HLE) B3 cells. Reactive oxygen species (ROS) generation in-
duced by PDGF was analyzed by luminescence assay. Cell
proliferation was measured by cell counting and by BrdU assay.
Human cPLA2 gene was cloned via RT-PCR followed by site-
directed mutagenesis to construct HLE B3 cells expressing
either inactive cPLA2 enzyme with S228A mutation (S228A),
or cPLA2 truncated at the calcium-binding C2 domain (C2D).
Activity of cPLA2 was measured by arachidonic acid (AA)
release from cell membranes using [3H]-arachidonic acid prela-
beled cells. The effect of intracellular calcium level on cPLA2
function was examined by treating cells with ionomycin (cal-
cium influx), thapsgargin (endoplasmic reticulum [ER] calcium
store release) or 1,2-bis(o-aminophenoxy)ethane-N,N,N,N-tet-
raacetic acid tetrakis (BAPTA; calcium chelator). Activation of
extracellular signal–regulated kinases (ERK), JNK, p38, or Akt
was detected by Western blot analysis using specific antibod-
ies.
RESULTS. S228A mutant showed suppressed PDGF-induced re-
active oxygen species generation, ERK and JNK activation (no
effect on p38 or Akt), and cell proliferation in comparison with
the vector alone (Vec) control. Calcium-binding C2 domain
cells lost the ability of membrane translocation and activation
of cPLA2. PDGF cell signaling was calcium-dependent, and
the calcium was supplied either from the external flux or
endoplasmic reticulum store. However, enrichment of cellular
calcium not only augmented PDGF function, but also demon-
strated a cPLA2-dependent calcium-signaling cascade that led
to cell proliferation.
CONCLUSIONS. cPLA2 is regulated by calcium mobilization and
mitogen-activated protein kinases (MAPK) activation. Both PDGF
mitogenic action and calcium signaling are cPLA2-dependent.
(Invest Ophthalmol Vis Sci. 2011;52:8231–8240) DOI:10.1167/
iovs.11-7542
Cytosolic phospholipase A2 (cPLA2) belongs to the largephospholipase A2 (PLA2) family that is widely involved in
various fundamental cellular physiological functions, including
neurochemical processes, normal brain function, regulation of
protein kinase C and modulation of ion channels.1,2 cPLA2 is
widely distributed in mammalian tissues and can be activated
by extracellular stimuli such as growth factors, cytokines, neu-
rotransmitters, or endotoxins,2 and selectively hydrolyzes glyc-
erophospholipids containing arachidonic acid (AA) at the sn-2
position. The released AA can be further metabolized to leu-
kotrienes, prostaglandins, or platelet-activating factor for vari-
ous biological needs.3–5 The subcellular localization and target
of cPLA2 may vary depending on the cell type; however,
cPLA2 requires cellular calcium binding at the C2 domain to
be translocated to the membrane for its catalytic action. For
instance, in endothelial cells, cPLA2 is mobilized from the
cytosol to the perinuclear region (endoplasmic reticulum,
Golgi, and nuclear envelope) where the AA produced is me-
tabolized to eicosanoids6 while in neutrophils and granulo-
cytes, cPLA2 is recruited to plasma membrane in which the
AAs released are needed for the generation of reactive oxygen
species (ROS) from NADPH oxidase. Translocating cPLA2 to
the membrane is an important step as it allows cPLA2 to be
phosphorylated and activated by ERK so that it can interact
with its phospholipid substrate on the membrane to release
AA.7 Serine residues in positions 228, 437, 454, 505, and 727 of
cPLA2 have been identified to be the sites of phosphorylation.
In particular, the site at Ser 228 is known to control cPLA2
activity.
Calcium ion (Ca2) is an important biological regulator,
which is broadly involved in various cellular signaling path-
ways of physiologic or pathologic events.8 The normally low
intracellular level of calcium can be enriched by mobilization
of the internal store in the endoplasmic reticulum (ER) or from
the extracellular medium. Typically, stimulation of G-protein
coupled receptor or tyrosine kinase receptors by outside stim-
uli can activate the isoforms of phospholipase C (PLC), which
in turn hydrolyzes phosphatidyl inositol 4,5-tri-phosphate
(PIP2) to release the secondary messenger of inositol triphos-
phate (IP3). The subsequent binding of IP3 to the receptor on
the ER membrane allows the calcium stored inside to be re-
leased into the cytoplasm. On the other hand Ca adenosine
triphosphatase (ATPase) located on the ER membrane can
pump calcium back into ER to replenish the store. Homeostasis
of intracellular calcium is essential to the health of cells and
tissues. For instance, it is known that calcium is needed in cell
proliferation,9 however, too great an influx of calcium or dis-
ruption of the ER store can both lead to cell death and dis-
eases.10–12 Recently, attention has been drawn to the relation-
ship between Ca2 and ROS with the demonstration that Ca2
is required in many ROS-related cellular activities,13,14 one of
which is cell proliferation.
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Sundaresan et al.15 first reported that platelet-derived
growth factor (PDGF) mitogenic action is mediated by ROS
generation. Bae et al.16 later showed that epidermal growth
factor (EGF) signaling for cell proliferation was also regulated
by ROS production. Therefore, redox signaling has been sug-
gested in many cell types to be the key regulator for growth
factor- and/or cytokine-induced cellular functions, including
cell proliferation, migration, and wound healing. Recently ROS
signaling has also been recognized as the essential regulator for
PDGF function in the lens17 and EGF function in the cornea.18
In both lens and corneal epithelial cells, cPLA2 was shown to
play a major role, as cPLA2 inhibition led to ceased ROS
generation from NADPH oxidase,19 and subsequently halted
cell proliferation, migration, and even wound healing in cells
stimulated with PDGF or EGF.18
Even though cPLA2 is critical for growth factor-induced
ROS generation in the lens epithelial cells,19 the detailed mech-
anism underlying cPLA2 activation and function remains un-
clear in the ocular tissues. While the cellular level of calcium,
especially that in the calcium store in ER, appears to be closely
associated with EGF-stimulated growth and survival of lens
epithelial cells,20 little is known about any possible role played
by calcium in the function of cPLA2 in ocular tissues. In the
present study, we have investigated the significance of calcium
ion in PDGF-induced ROS signaling by manipulating intracellu-
lar calcium level with ionomycin to increase external calcium
influx, thapsigargin to release ER calcium stores, or a chelating
agent to deplete calcium. We have examined the regulation of
cPLA2 by using a stable dominant-negative cPLA2 (S228A)
HLE B3 cell line, and a transient cell line with truncated C2
calcium binding domain (C2D) to examine their effects on
PDGF signaling. Our results indicate that an intact and active
cPLA2 as well as the presence of adequate intracellular cal-
cium are essential for PDGF-elicited ROS production and cell
proliferation. For simplicity, cPLA2 IV will be referred to as
cPLA2 from this point on in this report.
MATERIALS AND METHODS
Materials
Minimum Eagle essential medium (MEM) and fetal bovine serum (FBS)
were supplied by Invitrogen Corporation (Carlsbad, CA). HEPES, tryp-
sin, arachidonic acid, and lucigenin were obtained from Sigma-Aldrich
(St. Louis, MO). [3H]-AA was obtained from Amersham Biosciences Inc.
(Piscataway, NJ). Ionomycin, a calcium ioophore, thapisgargen, an
endoplasmic reticulum (ER) Ca2-ATPase inhibitor, and 1,2-bis-(o-
Aminophenoxy)-ethane-N,N,N,N-tetraacetic acid (BAPTA-AM), a cal-
cium-chelating agent, and arachidonyl trifluoromethyl ketone (AA-
COCF3), a specific inhibitor to cPLA2, were purchased from Biomol
International, LP (Plymouth Meeting, PA). The chemiluminescent sub-
strate (SuperSignal West Pico Chemiluminescent Substrate) and the
protease inhibitor (Halt Protease Inhibitor Cocktail) were from Pierce
Biotechnology, Inc. (Rockford, IL). Phospho-p42/44 MAPK (P-ERK1/
2), total ERK [ERK1/2], phospho-Akt (P-Akt), phospho-p38 (P-p38),
phospho-JNK (P-JNK), total JNK, cPLA2, and phospho-cPLA2 (P-cPLA2)
antibodies were purchased from Cell Signaling Technology Inc. (Bev-
erly, MA). Horseradish peroxidase-conjugated secondary antibodies
and glyceraldehyde-3-phosphodehydrogenase (G3PD) antibody were
from Santa Cruz Biotechnology (Santa Cruz, CA). Nitrocellulose mem-
brane (Hybond ECL) was from Amersham Biosciences Inc. (Piscat-
away, NJ). All chemicals were of reagent grade.
Cell Culture
The human lens epithelium (HLE) B3 cell line was a gift from Usha
Andley (Washington University, St. Louis, MO). The cells were cultured
in MEM containing 20% FBS until they reached confluence. Before
performing experiments, cells were cultured in MEM with 2% FBS
overnight followed by serum-free MEM for another 24 hours. For
experiments requiring Ca2-free conditions, MEM was first mixed with
2 mM EGTA for 30 minutes before use.
The Construction of Dominant-Negative cPLA2
(C228S) HLE B3 Stable Cell Line
Total RNA was extracted from HLE B3 cells using an RNA extraction kit
(Qiagen; Valencia, CA) and quantified by spectrophotometry. The RNA
was used for cDNA synthesis by in vitro reverse transcription. PCR was
performed by using specific primers: 5-ACGCGTATGTCATT-
TATAGATCCTTACCAGCAC-3 and 5-GTCGACCTATGCTTTGGGTT-
TACTTAGAAACTC-3.
The cloned cPLA2 was digested by restriction endonuclease and
ligased with expression vector (pCR3.1; Invitrogen). The site-directed
mutagenesis at 228th residue from serine to alanine (S228A) on cPLA2
was performed (QuickChange Site-Directed Mutagenesis Kit; Strat-
agene, La Jolla, CA) following manufacturer’s instructions. The expres-
sion vector containing the mutated insert was introduced into HLE-B3
cell by electroporation, and the cells were cultured in medium with
geneticin (G418, 1.0 mg/mL) for 4 weeks followed by single-colony
selection. Selected cPLA2-S228A cells were cultured in MEM containing
20% FBS until confluence and then stored in 80 °C for further use.
Generation of a Transient C2D HLEB3 Cell Line
To construct an expression vector containing cPLA2 without its C2
domain (residues 127–749), PCR was performed by using primers
flanking cPLA2 DNA sequence (nucleotide 379-2250) with appropriate
restriction enzyme cutting sites added: 5-GGGGAAGCTTATGGT-
CACTGAAATGGTTCTAGAAATGTCT-3 and 5-GTCGACCTATGCTTT-
GGGTTTACTTAGAAACTC-3. PCR product was cloned into expres-
sion vector (PCR3.1; Invitrogen) and the plasmid was named cPLA2-
C2D. HLE B3 cells were transiently transfected with cPLA2-C2D ex-
pression vector (Lipofectamine 2000; Invitrogen)-engaged system and
all procedures followed manufacturer’s instructions.
Detection of AA Release
Either wild type HLE-B3 or S228A mutant cells (1.3  106) were
incubated with 0.5 Ci/mL [3H]-AA for 15 hours. After incubation,
unincorporated [3H]-AA in the medium was removed, and the cells
were treated with 5 ng/mL PDGF. Aliquots of media (100 L) were
collected at 0 (control), 2.5, 5, 10, and 20 minutes and counted with a
scintillation counter for quantifying the released [3H]-AA.
Analysis of Cell Proliferation by Cell Counting
and BrdU Analysis
The detection of cell proliferation was done by using either manual cell
counting with a hemocytometer or by using a cell proliferation chemi-
luminescent assay kit (Roche Applied Science, Indianapolis, IN). The
protocol for BrdU analysis was based on manufacturer’s instructions
with slight modifications. In short, the trypsinized cells were cultured
on a 96-well plate (8  103 cells per well) in FBS-free medium for 24
hours. The MEM containing 5 ng/mL of PDGF was used to treat the
cells for 30 minutes. After treatment, each well was washed thoroughly
with MEM and loaded with MEM containing BrdU from the cell prolif-
eration chemiluminescent assay kit (Roche Applied Science). The cells
were incubated at 37 °C for 8 hours followed by the chemiluminescent
immunoassay for quantifying cell proliferation by using a luminometer.
Detection of ROS
The level of extracellular ROS released from cells was assayed using
lucigenin as a substrate based on the method of Zhang et al.19 with
slight modifications. Lucigenin interacts with free radicals such as
superoxide anion and emits luminescence, which can be quantitatively
detected and analyzed by a luminometer. The cells (1  106) were
trypsinized from the culture plates, washed thoroughly with PBS, and
kept in Krebs buffer (pH 7.4, 130 mM NaCl, 5 mM KCl, 2 mM MgCl2,
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1.8 mM CaCl2, 5 mM glucose, 35 mM phosphoric acid, 20 mM HEPES)
until further use. To measure ROS level, the cells were put in lumines-
cence buffer (Krebs buffer containing 0.5 mM lucigenin), and then
nicotinamide adenine dinucleotide phosphate (NADPH; 0.1 mM) was
added as the substrate. The emitted luminescence was detected with a
luminometer (FluoStar Optima; BMG Labtech, Durham, NC). For ex-
periments under calcium-free condition, a modified Krebs buffer was
prepared by replacing the 1.8 mM CaCl2 with 1.8 mM NaCl.
Manipulation of Intracellular Calcium Level with
Ionomycin, Thapsigargin or BAPTA-AM
Stock solutions of ionomycin and thapsigargin were prepared according
tomanufacturer’s instructions and stored in20 °C. Proper dilution of the
reagents was carried out before the experiment. An adequate amount of
HLE B3 cells were cultured on a 10-cm dish, 6-cm dish, or 96-well plate
depending on experiment needs. HLE B3 cells were cultured overnight in
MEM containing 2% FBS. For ROS detection or measurement of intracel-
lular calcium, the culture medium was changed to MEM containing iono-
mycin (0.01 M) or thapsigargin (0.01 M), or BAPTA-AM (5 M) for 30
minutes followed with or without PDGF stimulation. For BrdU-based cell
proliferation assay, the culture medium was changed to MEM containing
ionomycin (0.01 M) or thapsigargin (1 nM-10 M) or BAPTA-AM (5 M)
and cultured for 6 hours.
Detection of Intracellular Calcium Level in HLE
B3 Cells
The intracellular calcium levels were assayed (Fluo-4 Direct Calcium
Assay Kit; Invitrogen). All procedures in this experiment were done
following the manufacturer’s instructions. The detection of fluores-
cence, which represents the intracellular calcium level, was performed
with a fluorometer (FluoStar Optima; BMG Labtech) with excitation at
494 nm and emission at 516 nm.
Isolation of Cellular Membrane Fraction
The membrane fraction was isolated with the method used by Seth et
al.21 with modifications. Cells (6  106) were washed three times with
ice-cold PBS before being lysed by sonication in lysis buffer. The lysate
FIGURE 1. The effect of expressing dominant negative form of cPLA2 (S228A) on AA release and ROS
generation stimulated by PDGF in HLE cells. (A) Arachidonic acid release: cells were treated with PDGF
(5 ng/mL) and the medium was collected at different times as described. The released [3H]-AA in cell
culture medium was determined by scintillation counting. (B) Cell proliferation: Vec and S228A HLE B3
cells (8  105 per dish) were cultured in MEM containing 20% FBS for 48 hours. The cell number was
counted every 12 hours using a cell counter (Invitrogen). (C) DNA synthesis: proliferation of HLE B3 cells
expressing normal or S228A mutated cPLA2 induced by PDGF (5 ng/mL, 6-hour incubation) was detected
by determination of neosynthesized DNA with a BrdU-based cell proliferation chemiluminescent assay kit
(Roche Applied Science). The final result is the average of three independent experiments and is shown
as mean  SD. * P  0.05 versus Vec cells with the same treatment condition. (D) ROS production: cells
transfected with empty vector alone (Vec) and cells expressing cPLA2-S228A (S228A) were treated with
PDGF (5 ng/mL) and the levels of extracellular ROS within 5 minutes after PDGF stimulation were detected
using a lucigenin-based luminescence assay. The results are presented based on five independent exper-
iments and expressed as mean  SD. * P  0.05 compared with Vec cells of the same experimental
conditions.
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was centrifuged at 1000g to remove debris and nuclei and then cen-
trifuged at 100,000g to isolate the membrane and cytosolic fractions.
The supernatant (cytosolic fraction) was saved for future use and the
pellet was mixed in lysis buffer containing 1% Triton X-100 followed by
ultracentrifugation at 100,000g. The supernatant (membrane fraction)
was then collected for further experiments.
Western Blot Analysis
Cells (1.3  106) were washed thoroughly with ice-cold PBS and lysed
in 500 L lysis buffer containing 1% Triton X-100. The proteins in the
lysate (25 g/well) were separated by 10% SDS-PAGE, and transferred
to a nitrocellulose membrane (Hybond ECL; Amersham Biosciences
Inc.). After the transferring process, the membranes were blocked
with blocking solution containing 5% nonfat milk or 5% BSA and then
probed with anti- P-ERK1/2, ERK1/2, P-JNK, JNK, P-p38, P-Akt, cPLA2,
P-PLA2, or G3PD antibodies, respectively, based on the procedures
described by Chen et al.17 The immunoblots were labeled with horse-
radish peroxidase (HRP)-conjugated secondary antibodies and bands
were detected with an imaging system (VersDoc; Bio-Rad, Hercules,
CA) with enhancement by a chemiluminescence reagent.
Determination of Protein Concentration and
Statistical Analysis
All protein concentrations were measured by the BCA protein assay
according to Smith et al.22 For all tests, the data were analyzed using
Student’s t-test. A P value  0.05 was considered significant.
RESULTS
The S228A Mutation in cPLA2 Changes Its Enzyme
Activity and the Level of Cell Proliferation in HLE
B3 Cells
AA-release is widely used for measuring the enzyme activity of
cPLA2. To test if a point mutation at the active site of cPLA2
would obliterate its activity, we produced a dominant negative
form of cPLA2 (S228A) mutant and used it for this purpose.
After PDGF treatment, we found that the HLE B3 cells express-
ing the S228A mutant released much less free AA into the
medium than the HLE B3 cells transfected with vector alone
(Vec) (Fig. 1A), confirming that the S228A mutation reduces
the activity of cPLA2. We further examined the effect of the
S228A mutation on cell proliferation by manual cell counting
and by BrdU-based luminescence assay. After 12-hour incuba-
tion in MEM containing 20% FBS, a difference in cell numbers
was already apparent between the S228A and Vec cells. At the
end of 48 hours, the Vec cells had doubled, whereas the S228A
cells had only increased approximately 20% over the control
(Fig. 1B). By using BrdU-based luminescence assay, we were
able to quantify the neogenesis of cellular DNA for cell prolif-
eration. As shown in Figure 1C, within 6 hours of PDGF
treatment, the Vec cells show a 50% increase in DNA synthesis
over the unstimulated control, while the mutant cells display a
negligible increase. To understand the effect of mutated cPLA2
in ROS generation in HLE B3 cells, we used a luminescence
assay to measure PDGF-induced ROS generation from both Vec
and S228A cells. As shown in Figure 1D, in the absence of
PDGF, the S228A cells generate only about 25% of ROS in
comparison with the Vec cells. Treatment with PDGF induced
approximately 40% ROS increase in Vec cells but had essen-
tially no effect on S228A cells.
The Effect of the S228A Mutation and Calcium
Level on Membrane Translocation of cPLA2
The activation of cPLA2 is accompanied by membrane-translo-
cation phenomenon and is required for the PDGF-induced
signaling pathway, which leads to ROS generation and cell
proliferation.19,23,24 To examine how dominant negative cPLA2
could affect its translocation after PDGF stimulation, and
whether the translocation was calcium-dependent, we used
Western blot analysis to detect cPLA2 in the membrane fraction
isolated from Vec or S228A cells treated with and without
PDGF for 10 minutes. As shown in Figure 2, the translocation
of cPLA2 to the membrane fraction was observed in both Vec
and S228A cells after PDGF stimulation (see the normalized bar
graph). However, when the cells were pretreated with
BAPTA-AM (5 M)), a membrane-permeable Ca2 chelator to
sequester calcium, translocation of cPLA2 was extensively in-
hibited in both S228A and Vec cells (Fig. 2). It is worth noting
that the cPLA2 band was stronger in the S228A cells than in the
Vec cells (first and second rows) because the former overex-
pressed the mutant form of cPLA2. Gp91 (Gp91phox, the
major membrane NOX2) and glyceraldehyde-3-phosphate de-
hydrogenase (G3PD) were used as markers for membrane
protein and cytosolic protein, respectively, to ensure equal
protein loading.
The Effect of cPLA2-S228A Mutation on PDGF-
Induced Activation of Signaling Factors
It is well known in the upstream process of PDGF mitogenic
action that PDGF receptor binding can lead to its autophos-
phorylation with subsequent stimulation of the MAPK path-
way. The resultant activated ERK1/2, or P-ERK1/2, has been
suggested to be one of the kinases that can activate cPLA2
translocated on the membrane.23,25 To further examine the
effect of dominant negative cPLA2 on the activation of mito-
genic signaling factors, we performed Western blot analysis to
determine the phosphorylation or activation of MAPK family
FIGURE 2. The effect of calcium on PDGF-induced membrane trans-
location of cPLA2 in HLE cells. HLE B3 cells expressing cPLA2-S228
(S228A) or cells transfected with vector alone (Vec) were serum-
starved and treated with PDGF (5 ng/mL) for 10 minutes. Another set
of cells was pretreated with a calcium chelator (BAPTA-AM) before
PDGF stimulation. Cells were lysed and the membrane fractions were
isolated by ultracentrifugation. Western blot analysis was performed to
detect cPLA2 in both membrane (MEM) and cytosolic fraction (CYT).
Gp91 (Gp91phox, the major membrane subunit of NADPH oxidase 2
[NOX2]) and G3PD (glyceraldehyde-3-phosphate dehydrogenase)
were probed as loading controls for membrane and cytosolic fraction,
respectively. The quantitative results are based on the Western blot
analysis of cPLA2 normalized by reference to respective marker pro-
teins, and the magnitude (fold) of each is compared with Vec untreated
cells (normalized to 1.0). The data in the graphs are averages of three
independent experiments, and are presented as mean SD. * P 0.05
versus Vec cells without treatment. ** P  0.05 versus S228A cells
without treatment. C, control; P, PDGF treatment.
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proteins, including ERK1/2, JNK, and p38, and the survival
factor Akt. G3PD was also probed as a control for sample
loading. As shown in Figure 3A, P-ERK1/2 in Vec cells is
transiently induced by PDGF with the maxima activation at 10
minutes. However, mutation of cPLA2 weakened the transient
P-ERK1/2 and P-JNK signals throughout the entire 30 minutes
of the experiment, and lowered over 50% of the relative mag-
nitude of PDGF-induced activation (see the bar graph on the
normalized P-ERK1/2 and P-JNK in Fig. 3B). Mutation of cPLA2
showed no effect on total ERK, total JNK or P-Akt (Fig. 3A). As
expected, PDGF did not stimulate p38 and the mutation of
cPLA2 did not affect the P-p38 signal, which was included as a
negative control for the PDGF mitogenic study.
Effect of Intracellular Calcium Levels on ROS
Generation and Cell Proliferation
In many cell types, including the lens epithelial cells, the down-
stream PDGF mitogenic action depends on NADPH oxidase to
produce ROS to mediate cell proliferation.24 NADPH oxidase
activation requires the assembly of cytosolic subunits to be trans-
located onto the membrane in the proximity of the gp91 and p22
catalytical units.24 Calcium-dependent PKC activation plays a ma-
jor role in this critical event for ROS generation.19 To study the
possible collaboration between calcium and cPLA2 in PDGF-
induced redox signaling, we compared ROS production in both
Vec and S228A cells with and without PDGF stimulation under
the following conditions: no pretreatment; pretreated with iono-
mycin (Ca2 agonist); or pretreated with BAPTA-AM (Ca2 che-
lator). As shown in Figure 4A, the mutant cells have a very low
basal ROS level compared with the Vec cells, and no significant
PDGF-induced ROS increase is observed in S228A mutant cells
while the Vec cells responded to PDGF stimulation by generating
74% more ROS over the basal level. Ionomycin-induced calcium
influx into the Vec cells not only elevated the basal ROS in the
unstimulated cells but also augmented PDGF to produce nearly
83% more ROS over the nonstimulated control. By contrast, the
mutant cells did not respond to PDGF stimulation although the
basal ROS was elevated by the presence of ionomycin. However,
when the calcium in the medium was chelated by BAPTA-AM, no
FIGURE 4. The effect of calcium on PDGF-induced ROS generation
through cPLA2 in HLE cells. (A) HLE B3 cells expressing cPLA2-S228A
with or without the pretreatment of ionomycin or BAPTA-AM for 30
minutes were stimulated with PDGF (5 ng/mL) and the extracellular
ROS levels were detected within 5 minutes after PDGF stimulation by
lucigenin-based luminescence assay. The results are the average of five
independent experiments and are expressed as mean  SD. * P  0.05
versus Vec cells group in the same PDGF treatment condition. (B) HLE
B3 cells were treated with or without MEM containing PDGF (5
ng/mL), 20% FBS or ionomycin (0.01 M) for 6 hours, and the cell
proliferation was assayed by BrdU-based neosynthesized DNA quanti-
fication. The luminescence represents the level of neosynthesized DNA
as detected by a luminometer. The results are the average of three
independent experiments and are presented as mean  SD.
FIGURE 3. Comparison of the PDGF-induced activation of signaling
factors in HLE cells expressed intact and S228A cPLA2. (A) HLE B3 cells
expressing normal or S228A mutated cPLA2 were serum-starved and
treated with PDGF (5 ng/mL). Cell lysates were collected every 10
minutes, and Western blot analysis was performed to detect the phos-
phorylation of ERK, JNK, Akt, and p38, as well as the total protein
levels of ERK, JNK, Akt, and p38. G3PD was probed as loading control.
(B) The results of Western blot analysis in Figure 3A were analyzed
quantitatively and the bar graph showing P-JNK, P-ERK1/2, P-Akt, and
P-p38 was each normalized with total JNK, ERK1/2, Akt, and p38,
respectively. The magnitude (fold) of each is compared with Vec
untreated cells (normalized to 1.0). The Western blot analysis repre-
sents a typical pattern from three separate studies while the data in the
bar graphs are the averages of three independent experiments, and are
presented as mean  SD. * P  0.05 versus Vec cells without treat-
ment.
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significant ROS generation was detected in Vec cells with PDGF
stimulation, while the mutant cells remained nonresponsive to
PDGF (Fig. 4A).
Because the above results suggested that ionomycin could
independently stimulate ROS production besides augmenting
PDGF, we explored next if ionomycin was able to stimulate
cell growth and its association with cPLA2. Figure 4B shows the
BrdU analysis of cells cultured under various conditions, in
which both PDGF (5 ng/mL) and FBS (20%) provided positive
cell growth (positive controls) in comparison with that of the
untreated control. Interestingly, ionomycin at 0.01M was as
effective a cell growth stimulator as that of PDGF. These results
suggest that ionomycin-enriched intracellular calcium may
have initiated calcium signaling that is capable of mobilizing
and activating cPLA2 for the downstream process needed for
cell proliferation.
The Role of Endoplasmic Reticulum (ER)-Stored
Calcium in ROS Generation
To investigate the source of calcium used for NADPH oxidase
activation during PDGF mitogenic action, we compared PDGF-
stimulated ROS generation in HLE B3 cells under the condi-
tions of no treatment (control); pretreatment with ionomycin,
pretreatment with an ER calcium store-releasing agent (thapsi-
gargin), or pretreatment with a calcium binding agent (BAPTA-
AM). A parallel study was conducted with cells cultured in
regular medium (Fig. 5A) and cells cultured in calcium-free
medium (Fig. 5B). As shown in Figure 5A, both ionomycin and
thapsigargin pretreated cells are able to double the basal ROS
level over the control untreated cells, and amplified the cell’s
response to PDGF stimulation. BAPTA-AM pretreatment totally
eliminated the basal ROS elevation observed in ionophore and
thapsigargin treatment, and the cellular response to PDGF
stimulation. The same pattern for ROS generation was also
observed in cells cultured in calcium-free medium (Fig. 5B).
While thapsigargin is known to release calcium stored in the
ER specifically, ionomycin is also capable of releasing calcium
stored in the ER as well as infusing calcium extracellularly. Our
results confirmed this feature of ionomycin in the HLE B3 cells
(Fig. 5B). The same PDGF-stimulated ROS production, with and
without calcium in the medium, indicates that although cal-
cium may come from the extracellular source (Fig. 5A), the
calcium from the ER store is sufficient to carry out the PDGF
signaling function (Fig. 5B).
To further clarify the role of cPLA2 in calcium-mediated ROS
generation, we measured PDGF-induced ROS generation with a
lucigenin-based luminescence assay in Vec and S228A cells
cultured in calcium-free medium and pretreated 30 minutes in
the following conditions: no treatment (control), treated with
PDGF alone, treated with thapsigargin (10 M), or treated with
PDGF plus thapsigargin. As shown in Figure 5C, the S228A
mutant does not respond to any of the stimuli and its ROS level
is even less than the untreated control Vec cells. Interestingly
thapsigargin itself stimulated ROS generation as much as that of
PDGF, and displayed synergistic effect with PDGF. These data
suggest that calcium released from the ER store must have
mediated the PDGF-induced ROS generation, and also indepen-
dently initiated signaling events, but both requires an intact
cellular cPLA2.
Next we used the BrdU assay to examine if thapsigargin
could stimulate cell proliferation. HLE B3 cells were treated
with various affectors for 6 hours, including thapsigargin (1
nM), AACOCF3 (10 M, cPLA2 specific inhibitor), and thapsi-
gargin plus AACOCF3. We found that thapsigargin stimulated
FIGURE 5. The effect of ER-stored
calcium on ROS generation through
cPLA2 in HLE cells. (A) HLE B3 cells
were pretreated with ionomycin (10
minutes), thapsigargin (30 minutes),
or calcium-chelator BAPTA-AM (30
minutes), before PDGF stimulation.
The extracellular ROS levels at 10
minutes after PDGF treatment were
determined using the luciginin-based
luminescence assay. The results are av-
erages of three independent experi-
ments and are expressed as mean 
SD. * P  0.05 versus the control (Ctl)
group. (B) HLE B3 cells cultured in
EGTA-pretreated MEM (Ca2-free
MEM) for 1 hour were pretreated with
ionomycin (10 minutes), thapsigargin
(30 minutes), or BAPTA-AM (30 min-
utes), followed by PDGF stimulation.
The extracellular ROS levels at 10 min-
utes after PDGF stimulation were as-
sayed as before. The results are aver-
ages of three independent expe-
riments and are expressed as mean 
SD. * P  0.05 versus the Ctl cells
group. (C) HLE B3 cells transfected
with cPLA2-S228A or vector alone
were pretreated with or without thap-
sigargin for 30 minutes before stimula-
tion with or without PDGF (5 ng/mL).
The extracellular ROS levels were de-
termined by the lucigenin-based lumi-
nescence assay at 10 minutes after PDGF stimulation. The results are the averages of three independent experiments and are expressed as mean  SD.
* P  0.05 versus the same cell line in the Ctl group. (D) HLE B3 cells were treated with arachidonyl trifluoromethyl ketone (AACOCF3) at 10 M,
thapsigargin (1 nM), or thapsigargin (1 nM) plus AACOCF3 (10 M) for 6 hours followed by BrdU-based cell proliferation analysis. The results are the
averages of three independent experiments and are shown as mean  SD. * P  0.05 compared with the Ctl group.
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cell growth approximately 40% over the control, but this in-
crease was totally abolished and suppressed below the control
level when the cells were cotreated with a cPLA2 inhibitor,
similar to the level of suppression when cells were treated with
the inhibitor alone (Fig. 5D). This indicates that the mitogenic
effect triggered by the calcium released from the ER depends
on the activity of cPLA2. However, the positive effect of thap-
sigargin was only demonstrated when a low dosage of 1 nM
was used. Concentrations of thapsigargin at the range of 0.01
to 10 M all showed negative effects (data not shown).
The Intracellular Calcium Pool and the Effect on
ERK Activation
To investigate the possible mechanism of calcium-regulated
cell proliferation, we used ionomycin and thapsigargin to alter
the intracellular calcium level in HLE B3 cells and to detect the
activation of ERK1/2 signaling. Figure 6A shows that 20% FBS
increases intracellular calcium level approximately 30%, and
both ionomycin (0.01 M) and thapsigargin (10 M) can ele-
vate intracellular calcium 20% over that of the untreated HLE
B3 cells. Because ERK1/2 is one of the important MAPK sig-
naling factors that govern mitogenic effect, we investigated
whether pretreating cells with either thapsigargin or ionomy-
cin (30 minutes) could activate ERK1/2. We found that thap-
sigargin (10 M) and ionomycin (0.01 M) each transiently
activated ERK1/2, and the P-ERK1/2 signal peaked at 10 min-
utes and returned to near basal level at the end of 30 minutes
(Fig. 6B).
Calcium-Dependent Membrane Translocation
Affecting the Activity of cPLA2
To understand the relationship between the activation of
cPLA2 and its membrane translocation property, we trans-
fected HLE B3 cells with expression vector to overexpress the
C2 domain-deleted cPLA2 (cPLA2-C2D) of 70 kDa, and moni-
tored its membrane translocation by Western blot analysis.
Figure 7A shows that after 10 minutes of PDGF (5 ng/mL)
stimulation, cPLA2-C2D does not translocate to the membrane,
whereas the full-length cPLA2 (85 kDa) does. To investigate
whether the C2D-truncated cPLA2 can be activated by PDGF
treatment, we performed Western blot analysis to detect phos-
pho-cPLA2 (phosphorylated at Ser505), which is known to be
the location governing enzyme activity and a phosphorylation
target of ERK1/2. Figure 7B shows that none of the cPLA2-C2D
is phosphorylated at Ser505 (indicated by an arrow head in the
upper panel). However, a small amount of P-cPLA2 from the
endogenous full-length cPLA2 in the C2D cells could be de-
tected, same as that of the Vec cells (see the arrow at the upper
panel, and the bar graph below). These results indicate that the
activation of cPLA2 requires its C2 domain, and the event of
translocation precedes activation.
DISCUSSION
In a previous study, we have found that when cPLA2 is inhib-
ited by a chemical inhibitor (AACOCF3), exogenous AA can
intercept and directly process the downstream signals to stim-
ulate ROS generation in human lens epithelial cells, and we
have thus proposed that cPLA2-released AA can provide posi-
tive feedback regulation of PDGF and amplify the mitogenic
signaling.19 Our current results suggest that the reason cPLA2
mutated at S228A could not respond to PDGF-induced ROS
production or cell proliferation is likely due to its inability to
release sufficient AA from membrane phospholipids to aid the
activation of NADPH oxidase for ROS production and subse-
quent cell proliferation (Fig. 1). The S228A mutant with inac-
FIGURE 6. Intracellular calcium level
and ERK1/2 activation. (A) Serum-
starved HLE B3 cells were treated with
20% FBS, ionomycin (0.01 M), or
thapsigargin (10 M) for 30 minutes
before measuring calcium level. The
relative intracellular calcium levels
were detected (Fluo-4 Direct Calcium
Assay Kit; Invitrogen). The results are
the average of three independent ex-
periments and are presented as
mean SD. * P 0.05 compared with
cells in the Ctl group. (B) HLE B3 cells
were treated with 10 M thapsigargin
or 0.01 M ionomycin for 30 minutes
and the lysate was collected at 0, 10,
20, and 30 minutes. Western blot anal-
ysis was performed to detect phospho-
ERK1/2 and total ERK1/2. The level of
P-ERK1/2 was quantified and normal-
ized against total ERK1/2. * P  0.05
versus cells with no treatment (normal-
ized to 1.0).
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tive cPLA2 made in this study agrees with the reports in the
literature,2 and also confirm that the active site of cPLA2 in lens
epithelial cells is similar to that of other cell types. The mutant
cell line grew more slowly than the Vec cells but the cells were
still viable with no obvious sign of cell death. It has been
reported that genetic deletion of cPLA2 in mice did not lead to
a significant change in life span or any obvious phenotypic
defects,4,26 indicating that defected cPLA2 in cells or tissues
may be overridden by other compensatory pathways.
Membrane translocation is an important event in the acti-
vation process of cPLA2. The translocation is not only required
for interaction between cPLA2 and its substrate (phospholip-
ids) but also allows cPLA2 to move closer to other downstream
enzymes in AA metabolism, such as lipoxygenase (LOX) and
cyclooxygenase (COX),6 and other target proteins such as
NADPH oxidase for ROS generation.27,28 It has been reported
that translocation of PLA2 family enzymes can be calcium-
dependent (cPLA2) and calcium-independent (iPLA2). How-
ever, cPLA2 IV isozyme examined in the present study is
known to be calcium-dependent in other cell types.29 Our data
also clearly demonstrated that calcium is required for cPLA2
membrane translocation in the lens epithelial cells (Fig. 2). In
addition, cPLA2 carrying S228A mutation could still be translo-
cated onto the membrane as long as calcium was available in
the microenvironment. It has been demonstrated that cPLA2
has a calcium-dependent phopholipid binding domain (C2D)
located in the N-terminal region.30 The mutation of S228A
apparently does not disturb this membrane-binding region.
Our data also clearly demonstrated that the presence of
calcium binding C2 domain on cPLA2 is essential for this
translocation as cPLA2 without the C2 domain (the C2D mu-
tant) lost the ability to move onto the membrane with or
without intracellular calcium (Fig. 7A). Furthermore, the acti-
vation or phosphorylation of cPLA2 requires it to be in place on
the membrane where a MAP kinase, such as ERK1/2, can
phosphorylate at Ser505 and activate the enzyme. Therefore,
the cPLA2 mutant truncated at the C2 domain was also unable
to be activated. The mass difference between the intact cPLA2
(85 kDa) and the shortened cPLA2-C2D (70 kDa), allowed the
two proteins to be separated quite clearly on the gel. There-
fore, the Western blot analysis (Fig. 7B) was able to distinguish
a transiently intensified P-cPLA2 at 10 minutes post-PDGF treat-
ment, which was the nascent and intact cPLA2 expressed in the
transient mutant cells, while the major bulk of cPLA2-C2D
expressed as the 70 kDa protein remained unphosphorylated
on PDGF stimulation.
Many different signaling factors are involved in cell prolif-
eration. Previously, we have found in lens epithelial cells17,19
that PDGF or AA were able to induce transient activation of cell
signaling factors, including mitogen-activated protein kinase/
ERK kinase (MEK), ERK1/2, and JNK.19,24 We have also ob-
served that inhibition of MEK activation by U0126, not only
FIGURE 7. The relationship between the C2 domain and the activation of cPLA2. (A) HLE B3 cells
expressing cPLA2-C2D (C2D) were stimulated with 5 ng/mL PDGF for 10 minutes. The cells were then
lysed and the membrane (mem) and cytosolic (cyt) fractions were separated by ultracentrifugation before
performing Western blot analysis to detect endogenous cPLA2 and cPLA2-C2D. HLE B3 cells transfected
with vector alone were used as control (Vec). Each lane contains 40 g of protein. The level of cPLA2 was
quantified based on three independent experiments and expressed as mean  SD. * P  0.05 versus
membrane fraction of Vec cells without treatment. (B) HLE B3 cells transfected with vector alone (Vec)
or cPLA2-C2D (C2D) were treated with 5 ng/mL PDGF for 30 minutes and the lysates were collected at
0, 10, 20, and 30 minutes of treatment. Western blot analysis was performed to detect cPLA2 and
phospho- cPLA2. Each lane contains 25 g of protein and the result represents a typical outcome of three
independent repeats. The level of P-cPLA2 was quantified based on three independent experiments and
expressed as mean  SD. * P  0.05 versus Vec cells without treatment (normalized to 1.0).
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prevented the downstream ERK1/2 from activation, but also
eliminated the cell’s response to PDGF stimulation for ROS
production or cell proliferation.19 In the present study, we
observed that the PDGF-induced transient activation of ERK1/2
and JNK was present, likely due to the basal cPLA2 that is
expressed in the mutant cells. However, the signals during the
entire 30 minutes of PDGF stimulation were much lower (ap-
proximately 50%) than that of the Vec cells (Fig. 3). Impor-
tantly, the signal loss in P-ERK1/2 and P-JNK (Fig. 3A) corrob-
orated with the lowered ROS level (Fig. 4A) and the suppressed
growth rate (Fig. 1B) observed in the same mutant. This sup-
pressed activation of JNK and ERK1/2 in S228A mutant implies
that the role of AA as a positive feedback regulator for PDGF
signaling is compromised due to the deficient AA release from
a defective cPLA2. p38, which is known as the cellular stress
signal, showed no difference between the Vec and S228A cells
(Fig. 3), indicating that both cell populations were not stressed
during the experimental conditions.
Interestingly, the activation of Akt induced by PDGF was
not affected by the S228A mutation in cPLA2. It has been
suggested that Akt controls cell survival and proliferation sig-
nals, and that Akt can be highly activated by the treatment of
PDGF.31–33 No change in PDGF-induced Akt phosphorylation
between Vec and S228A cells may indicate that Akt is not a
downstream factor in cPLA2-related mitogenic cell signaling
pathways. This phenomenon also suggests that cPLA2 may
govern multiple PDGF-induced ROS sources leading to the
induction of different downstream factors such as JNK,
ERK1/2, and Akt. Further studies on this direction of research
are required.
The association of calcium signaling with cell proliferation
has been studied extensively in many cell types,8 including lens
epithelial cells,34,20 however, the requirement of calcium ion
for growth factor-induced ROS generation has never been
explored in ocular tissues or cells. Our present study clearly
showed (Figs. 4A and 5A and B) that calcium ion was required
for PDGF-induced ROS generation in HLE B3 cells, and that a
calcium ionophore showed synergism with PDGF (Fig. 4A).
This finding is in agreement with the observation in lympho-
cytes, in which another calcium ionophore A23187 synergized
with PMA, a PKC activator, promotes cell growth.35 Interest-
ingly, ionomycin alone raised the basal level of ROS in both Vec
and S228A mutant cells but the effect was eliminated in the
presence of a calcium chelator (Fig. 4A), indicating that the
elevated intracellular calcium could stimulate the native cPLA2
expressed in the quiescent mutant and the Vec cells. Thus, it is
not surprising that ionomycin stimulated cell proliferation as
efficiently as PDGF shown in Figure 4B.
Besides the influx from external sources, intracellular cal-
cium can also be enriched from the internal stores, induced by
the growth factor receptor-IP3 signaling processes. Wang et
al.20 showed that thapsigargin-induced calcium release from ER
stores could transiently elevate internal calcium level, which
either impeded serum or EGF-stimulated cell growth or elicited
cell death, depending on the concentration of thapsigargin
used (0.1–1 M). In our present study, we have found that cells
pretreated by thapsigargin at a low level (1 nM) could stimulate
cell growth (Fig. 5D), which was suppressed to below the level
of control cells when a specific inhibitor (AACOCF3) was
present. Additionally, in a 30-minute pretreatment study,
higher level of 10 M thapsigargin directly stimulated ROS
production as effectively as that of PDGF in Vec cells but not in
S228A mutant (Fig. 5C). Apparently such a physiological func-
tion of thapsigargin is only effective when the enzyme cPLA2 is
intact. In addition, thapsigargin, similar to ionomycin, could
stimulate a transient ERK1/2 activation (Fig. 6B), indicating a
crosstalk between calcium signaling and MAPK pathway, sim-
ilar to other cell types.8
Wang et al.20 also observed activation of ERK1/2 in thapsi-
gargin-treated cells, but their other results contradicted with
ours. This may possibly be due to the differences in experi-
mental conditions as we only used thapsigargin to pretreat the
cells for 30 minutes before embarking on various studies while
Wang et al.20 placed thapsigargin in the cell culture medium
during the entire incubation period of 24 hours. We also
observed an adverse effect of thapsigargin at dosage  1 nM
when conducting the 6-hour BrdU cell proliferation studies
(data not shown). This is reasonable because many agents do
display an opposite effect, depending on the dosage and dura-
tion of exposure as we have experienced with N-acetylcysteine
during treatment of corneal wound healing.18
In conclusion, our findings indicate that cPLA2 in the lens
epithelial cells is regulated by the calcium binding-assisted
membrane translocation for its orientation and activation on
the membrane. The intact enzyme is necessary for the down-
stream NADPH oxidase activation and ROS production in the
PDGF-stimulated cell growth of HLE B3 cells. Both ionomycin
and thapsigargin raised intracellular calcium level as much as
those of fetal bovine serum (Fig. 6A), and our data indicate that
this influx of calcium appears to participate in cPLA2 regula-
tion. Our present study not only clarified the regulatory mech-
anism for cPLA2 and its association with PDGF mitogenic
action, it also revealed for the first time that a cPLA2-dependent
calcium signaling for cell proliferation is present in the HLE B3
cells, and likely in other cell types.
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